ANVISA guidelines for two-stage design [Two-Stage / GS Designs]

posted by nobody – 2020-02-12 07:49 (343 d 18:46 ago) – Posting: # 21163
Views: 3,540

» » Art.75. For two-stage studies, the following should be noted: It is acceptable to use a two-stage approach to demonstrate bioequivalence based on ignorance of the intra-individual variability of the drug;
»
»
» Ermmm...... WHAT???? :-D:party:

Same reaction here last night, but I thought I'm hallucinating due to ovewr-day fasting.

Kindest regards, nobody

Complete thread:

Activity
 Admin contact
21,308 posts in 4,444 threads, 1,489 registered users;
online 5 (0 registered, 5 guests [including 2 identified bots]).
Forum time: Thursday 02:35 UTC (Europe/Vienna)

Politicians use statistics like drunkards use lampposts:
not for illumination, but for support.    attributed to Hans Kuhn

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5